Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) shares, rose in value on Friday, November 01, with the stock price up by 1.53% to the previous day’s close as strong demand from buyers drove the stock to $7.32.
Actively observing the price movement in the last trading, the stock closed the session at $7.21, falling within a range of $7.16 and $7.37. The value of beta (5-year monthly) was 1.445. Referring to stock’s 52-week performance, its high was $10.05, and the low was $4.71. On the whole, AUPH has fluctuated by 4.27% over the past month.
With the market capitalization of Aurinia Pharmaceuticals Inc currently standing at about $1.05 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2024-Nov-07.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 234.15M, with a low estimate of 54.5M and a high estimate of 67.3M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 57.69M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that AUPH’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of AUPH currently trading nearly 3.01% and 4.19% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 57.03, while the 7-day volatility ratio is showing 3.06% which for the 30-day chart, stands at 2.96%. Furthermore, Aurinia Pharmaceuticals Inc (AUPH)’s beta value is 1.46, and its average true range (ATR) is 0.22.
A comparison of Aurinia Pharmaceuticals Inc (AUPH) with its peers suggests the former has fared considerably weaker in the market. AUPH showed an intraday change of 1.53% in last session, and over the past year, it grew by 2.66%%.
Data on historical trading for Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) indicates that the trading volumes over the past 10 days have averaged 0.87 and over the past 3 months, they’ve averaged 1.22 million. According to company’s latest data on outstanding shares, there are 143.83 million shares outstanding.
Nearly 10.01% of Aurinia Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 40.36% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 7.19 million shares as on 2024-10-15, resulting in a short ratio of 7.21. According to the data, the short interest in Aurinia Pharmaceuticals Inc (AUPH) stood at 506.00 of shares outstanding as of 2024-10-15; the number of short shares registered in 2024-09-13 reached 7.58 million. The stock has fallen by -18.58% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the AUPH stock heading into the next quarter.
